taxifolin and Cirrhosis

taxifolin has been researched along with Cirrhosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Ma, BL; Wang, W; Xu, CG; Zhou, XJ1
Chen, Y; Cui, Y; Guo, H; Guo, Y; Shan, T; Wu, D; Xu, D; Zhang, F; Zhang, X; Zhou, H1

Other Studies

2 other study(ies) available for taxifolin and Cirrhosis

ArticleYear
Dihydroquercetin protects against renal fibrosis by activating the Nrf2 pathway.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2020, Volume: 69

    Topics: Animals; Fibrosis; Hydrogen Peroxide; Kidney; Kidney Diseases; Male; Mice, Inbred C57BL; NF-E2-Related Factor 2; Oxidative Stress; Phosphorylation; Protective Agents; Quercetin; Rats; Signal Transduction; Smad3 Protein; Transforming Growth Factor beta; Ureteral Obstruction

2020
Taxifolin protects against cardiac hypertrophy and fibrosis during biomechanical stress of pressure overload.
    Toxicology and applied pharmacology, 2015, Sep-01, Volume: 287, Issue:2

    Topics: Angiotensin-Converting Enzyme 2; Animals; Cardiomegaly; Dose-Response Relationship, Drug; Electrocardiography; Fibrosis; Mice; Myocytes, Cardiac; Oxidative Stress; Peptidyl-Dipeptidase A; Quercetin; Reactive Oxygen Species; Signal Transduction

2015